Ondansetron Injection I.P. 4mg (2ml)

Ondansetron Injection I.P. 4 mg (2 mL)
Fast Relief from Nausea & Vomiting — When It Matters Most

Ondansetron Injection I.P. 4 mg is a potent, selective 5-HT₃ receptor antagonist designed to provide rapid and reliable relief from nausea and vomiting caused by chemotherapy, radiotherapy, and postoperative recovery. With its fast-acting injectable formulation, it is ideal for use in hospitals, oncology centers, and surgical wards.

Key Benefits:

• Rapid Onset of Action:
  Provides quick control of acute nausea and vomiting via IV or IM route—ideal when oral administration is not feasible.

• Targeted Anti-Emetic Therapy:
  Blocks serotonin receptors in both the central nervous system and GI tract to control both central and peripheral causes of nausea.

• Well-Tolerated & Safe:
  Minimal sedation and low incidence of side effects make it suitable for a wide range of patients, including children and the elderly.

• Versatile Use Across Specialties:
  Widely used in oncology, surgery, emergency medicine, and gynecology.

Indications:

• Prevention and treatment of chemotherapy-induced nausea and vomiting (CINV)

• Radiotherapy-induced nausea and vomiting

• Postoperative nausea and vomiting (PONV)

• Gastroenteritis-related nausea

Dosage & Administration:
Each 2 mL ampoule contains 4 mg of Ondansetron. Administered via intravenous or intramuscular injection. Dosage as per physician’s direction, depending on indication and patient profile.

Important Safety Information:
Generally well tolerated. Use with caution in patients with prolonged QT interval or electrolyte imbalances. Monitor cardiac function in high-risk individuals.